RYTM (STOCKS)
Rhythm Pharmaceuticals, Inc. Common Stock
$86.810000
+2.420000 (+2.87%)
Prev close: $84.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David P. Meeker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,923.04M
- Employees
- 283
- P/E (TTM)
- -27.92
- P/B (TTM)
- 40.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $189.76M |
| Benefits Costs and Expenses | $385.80M |
| Cost Of Revenue | $19.49M |
| Costs And Expenses | $381.77M |
| Gross Profit | $170.27M |
| Nonoperating Income/Loss | -$4.03M |
| Operating Expenses | $362.28M |
| Selling, General, and Administrative Expenses | $194.94M |
| Research and Development | $167.34M |
| Operating Income/Loss | -$192.02M |
| Income/Loss From Continuing Operations After Tax | -$196.54M |
| Income/Loss From Continuing Operations Before Tax | -$196.04M |
| Income Tax Expense/Benefit | $497.00K |
| Income Tax Expense/Benefit, Current | $497.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$196.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$196.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$201.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $5.38M |
| Preferred Stock Dividends And Other Adjustments | $5.38M |
| Basic Earnings Per Share | -$3.11 |
| Diluted Earnings Per Share | -$3.11 |
| Basic Average Shares | 64,984,361 |
| Diluted Average Shares | 64,984,361 |
| Assets | $480.20M |
| Current Assets | $466.92M |
| Cash | $388.90M |
| Inventory | $25.75M |
| Other Current Assets | $52.26M |
| Noncurrent Assets | $13.28M |
| Fixed Assets | $1.10M |
| Other Non-current Assets | $12.18M |
| Liabilities | $210.17M |
| Current Liabilities | $105.94M |
| Accounts Payable | $13.95M |
| Other Current Liabilities | $92.00M |
| Noncurrent Liabilities | $104.23M |
| Equity | $139.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $139.07M |
| Temporary Equity | $130.96M |
| Temporary Equity Attributable To Parent | $130.96M |
| Liabilities And Equity | $480.20M |
| Net Cash Flow From Operating Activities | -$115.68M |
| Net Cash Flow From Operating Activities, Continuing | -$115.68M |
| Net Cash Flow From Investing Activities | -$137.15M |
| Net Cash Flow From Investing Activities, Continuing | -$137.15M |
| Net Cash Flow From Financing Activities | $217.96M |
| Net Cash Flow From Financing Activities, Continuing | $217.96M |
| Net Cash Flow | -$34.87M |
| Net Cash Flow, Continuing | -$34.87M |
| Comprehensive Income/Loss | -$202.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$202.67M |
| Other Comprehensive Income/Loss | -$6.14M |